After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CDTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Cidara Therapeutics Inc is $1.37B. A total of 0.56 million shares were traded on the day, compared to an average of 691.02K shares.
In the most recent transaction, RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares of CDTX for 44.00 per share on Jun 26 ’25. After the transaction, the Director now owns 3,365,523 company shares. In a previous transaction on Jun 02 ’25, Mineo Chrysa bought 2,270 shares at 21.71 per share. CDTX shares that Director owns now total 2,270.
Among the insiders who bought shares, Mineo Chrysa acquired of 1,050 shares on Jun 03 ’25 at a per-share price of $23.44. This resulted in the Director holding 3,320 shares of CDTX after the transaction. In another insider transaction, Ward Shane sold 1,664 shares at $21.96 per share on Mar 11 ’25. Company shares held by the COO & CLO now total 14,674.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CDTX has a high of $66.94 and a low of $10.14.
As of this writing, CDTX has an earnings estimate of -$1.82 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$1.19 per share and a lower estimate of -$2.31. The company reported an EPS of -$20.65 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CDTX’s latest balance sheet shows that the firm has $59.68M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $34.02M in liabilities at the time. Its Book Value Per Share was $11.60, while its Total Shareholder’s Equity was $21.57M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
